Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral resolution method for captopril intermediate ensures high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Patent CN110938028B details a cost-effective, three-step synthesis of high-purity (1R)-5-bromo-2,3-dihydro-1-methyl-1H-isoindole, optimizing supply chain stability for quinolone antibiotics.
Patent CN115246815A details a novel nicotine preparation method recycling chiral resolution waste, offering high purity and reduced environmental impact for pharmaceutical manufacturers.
Novel patent CN117447387A enables cost-effective chiral intermediate production. Enhances supply chain reliability and purity for global API manufacturing partners.
Novel green synthesis of Dapoxetine from acetophenone. Improved yield, reduced waste, scalable industrial process for pharmaceutical intermediates.
Patent CN112479876A reveals a novel chiral resolution route for oxazepine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover the advanced chemical synthesis of epidaunorubicin intermediates via patent CN109293613B. Offers superior purity and supply stability over fermentation methods.
Patent CN102603592B reveals a novel DBTA resolution method for chiral aminopyrrolidines, offering high yield and optical purity for pharmaceutical supply chains.
Novel patent CN102757431B details cost-effective Sitagliptin synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Patent CN112020498B details a scalable Brivaracetam intermediate route eliminating chromatography. This offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN103333111A reveals a low-cost synthesis for Lorcaserin HCl. Discover how this novel route reduces production cycles and enhances supply chain reliability for obesity drug intermediates.
Novel process for (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane synthesis offering superior yield and purity for reliable API intermediate supply chains.
Patent CN114014874A reveals a cyclic resolution method for Baloxavir intermediates, significantly reducing waste and improving yield for reliable pharmaceutical intermediate supply chains.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.
Novel method for (R)/(S)-6,6'-dihydroxy-5,5'-bisquinoline using CuCl2 oxidation and crystallization resolution, offering high purity and scalable production for pharma intermediates.
Patent CN111187255B reveals a mild, high-purity synthesis route for D-ilaprazole. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Patent CN115611811B reveals chiral ionic liquid technology for high-purity L-Threonine resolution offering significant supply chain and cost advantages.
Patent CN111233931B details a novel Remdesivir synthesis using Lewis acid catalysis. Discover cost-effective, scalable manufacturing solutions for high-purity antiviral intermediates.
Patent CN109912624A reveals a streamlined synthetic route for Baloxavir marboxil intermediates, offering significant supply chain reliability and cost advantages for pharmaceutical manufacturers.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.